To assess the effect of Swarna-prashana on delivery induced complications in newborn baby.

A Clinical Study to Evaluate the Efficacy of Swarna Bhasma as Swarna-prashana in Combating Oxidative Stress in Neonates

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/04/013513

Enrollment

Registered

2018-04-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Swarna Bhasma as Swarna prashan: Dose of Swarnabhasma: 15 mg (1/8 Ratti) Dose of Ghrita: 6 drops (approx. 360 mg) Dose of madhu: 10 drops(as per palatability) Only on first day of life

Eligibility

Inclusion criteria

Inclusion criteria: Newly born baby of age less than 1 hour to 3 hours will be included in the study. A FT (AGA)baby without any congenital/hereditary disorder.

Exclusion criteria

Exclusion criteria: If mother of the child had any systemic illness during antenatal period. Preterm, VLBW and ELBW babies Congenital and hereditary disorders.

Design outcomes

Primary

Measure	Time frame
Superoxide dismutase, catalase, glutathione content in RBC haemolysateTimepoint: At birth and on 3rd day	—

Secondary

Measure	Time frame
Health status of the baby in terms of growth and development along with morbidity and mortality of the children (if any)Timepoint: At an interval of 1 month, upto 3 months	—

Countries

India

Contacts

Public ContactSmriti Singh

Institute of Medical Sciences, B.H.U

hodkb2006@yahoo.in9415286910

Outcome results